Literature DB >> 9499536

[Value of diagnostic laparoscopy and minimal invasive procedures in acute abdomen].

H W Waclawiczek1, V Schneeberger, A Bekk, A Dinnewitzer, P Sungler, O Boeckl.   

Abstract

During the last three years 172 diagnostic laparoscopies (DL) were performed at our department in patients with an acute abdomen of unclear causes. This corresponds to 17% of all patients who underwent operation due to an acute abdomen in the same period. Always the indication for a diagnostic laparoscopy arose then, when the cause or the localization of the acute abdomen could not be found by conventional diagnostic methods. The advantages of DL were either the confirmation (93%) or the exclusion (7%) of the diagnosis "acute abdomen", the exact localization and simultaneously a definitive operative treatment of the cause by minimal invasive interventions (n = 109/65%). In these patients with acute abdomen the main causes were acute inflammations of gallbladder (n = 48) and appendix (n = 29), ulcus perforations (n = 9) and ileus (n = 9). The conversion rate amounted to 2.7%, the postoperative complication rate to 11% and the lethality rate to 1.8% in these patients. A new indication is the so-called "bedside laparoscopy" as means to control the postoperative course of mesenteric embolism (n = 9) and diffuse peritonitis (n = 3) in order to avoid the stress of a second-look operation for these seriously ill patients or to secure the indication for relaparotomy.

Entities:  

Mesh:

Year:  1997        PMID: 9499536

Source DB:  PubMed          Journal:  Zentralbl Chir        ISSN: 0044-409X            Impact factor:   0.942


  2 in total

Review 1.  [Diagnostic laparoscopy in acute abdomen].

Authors:  R Keller; M Kleemann; P Hildebrand; U J Roblick; H-P Bruch
Journal:  Chirurg       Date:  2006-11       Impact factor: 0.955

Review 2.  Laparoscopy for abdominal emergencies: evidence-based guidelines of the European Association for Endoscopic Surgery.

Authors:  S Sauerland; F Agresta; R Bergamaschi; G Borzellino; A Budzynski; G Champault; A Fingerhut; A Isla; M Johansson; P Lundorff; B Navez; S Saad; E A M Neugebauer
Journal:  Surg Endosc       Date:  2005-10-24       Impact factor: 3.453

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.